Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP726916.RAEMCLYVTavn0bYsB-yvO9cJm9ShUtHN-CBgZJC_TG50A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP726916.RAEMCLYVTavn0bYsB-yvO9cJm9ShUtHN-CBgZJC_TG50A130_assertion type Assertion NP726916.RAEMCLYVTavn0bYsB-yvO9cJm9ShUtHN-CBgZJC_TG50A130_head.
- NP726916.RAEMCLYVTavn0bYsB-yvO9cJm9ShUtHN-CBgZJC_TG50A130_assertion description "[Diagnostic needle biopsies from prostate cancer patients primarily treated by endocrine therapy were evaluated for TMPRSS2:ERG fusion with fluorescence in situ hybridization and SPINK1 protein expression with immunohistochemistry.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP726916.RAEMCLYVTavn0bYsB-yvO9cJm9ShUtHN-CBgZJC_TG50A130_provenance.
- NP726916.RAEMCLYVTavn0bYsB-yvO9cJm9ShUtHN-CBgZJC_TG50A130_assertion evidence source_evidence_literature NP726916.RAEMCLYVTavn0bYsB-yvO9cJm9ShUtHN-CBgZJC_TG50A130_provenance.
- NP726916.RAEMCLYVTavn0bYsB-yvO9cJm9ShUtHN-CBgZJC_TG50A130_assertion SIO_000772 20442300 NP726916.RAEMCLYVTavn0bYsB-yvO9cJm9ShUtHN-CBgZJC_TG50A130_provenance.
- NP726916.RAEMCLYVTavn0bYsB-yvO9cJm9ShUtHN-CBgZJC_TG50A130_assertion wasDerivedFrom befree-20140225 NP726916.RAEMCLYVTavn0bYsB-yvO9cJm9ShUtHN-CBgZJC_TG50A130_provenance.
- NP726916.RAEMCLYVTavn0bYsB-yvO9cJm9ShUtHN-CBgZJC_TG50A130_assertion wasGeneratedBy ECO_0000203 NP726916.RAEMCLYVTavn0bYsB-yvO9cJm9ShUtHN-CBgZJC_TG50A130_provenance.